Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Prokop

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Studies in Health Technology and Informatics|June 24, 2020
Automated Analysis of the Heterogeneity of Histological Glioblastoma Slides Using Neural NetworksMichael Oertl, Georg Prokop, Felix Holl, et al.
GMS Journal for Medical Education|June 26, 2023
OPEN Hackathon at the TUM School of Medicine, GermanyKatharina Mosene, Celestine Kleinesper, Georg Prokop, et al.
Studies in Health Technology and Informatics|January 22, 2022
Quantifying Heterogeneity in Tumors: Proposing a New Method Utilizing Convolutional Neuronal NetworksGeorg Prokop, Michael Örtl, Marina Fotteler, et al.
Frontiers in Oncology|May 9, 2022
Glioblastoma Relapses Show Increased Markers of Vulnerability to FerroptosisHelena Kram, Georg Prokop, Bernhard Haller, et al.
Current Oncology (Toronto, Ont.)|October 22, 2021
Spinal Manifestation of Malignant Primary (PLB) and Secondary Bone Lymphoma (SLB)Melanie Barz, Kaywan Aftahy, Insa Janssen, et al.
International Journal of Cancer|July 28, 2023
Multiscale quantification of morphological heterogeneity with creation of a predictor of longer survival in glioblastomaGeorg Prokop, Benedikt Wiestler, Daniel Hieber, et al.
EJNMMI Research|August 16, 2021
Visualizing cellularity and angiogenesis in newly-diagnosed glioblastoma with diffusion and perfusion MRI and FET-PET imagingFriederike Liesche-Starnecker, Georg Prokop, Igor Yakushev, et al.
Cancers|May 11, 2024
Quantitative Assessment of Tumor Contact with Neurogenic Zones and Its Effects on Survival: Insights beyond Traditional PredictorsKirsten Jung, Johanna Kempter, Georg Prokop, et al.
Cancers|October 17, 2020
Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human GlioblastomaFriederike Liesche-Starnecker, Karoline Mayer, Florian Kofler, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Studies in Health Technology and Informatics|June 24, 2020
Automated Analysis of the Heterogeneity of Histological Glioblastoma Slides Using Neural NetworksMichael Oertl, Georg Prokop, Felix Holl, et al.
GMS Journal for Medical Education|June 26, 2023
OPEN Hackathon at the TUM School of Medicine, GermanyKatharina Mosene, Celestine Kleinesper, Georg Prokop, et al.
Studies in Health Technology and Informatics|January 22, 2022
Quantifying Heterogeneity in Tumors: Proposing a New Method Utilizing Convolutional Neuronal NetworksGeorg Prokop, Michael Örtl, Marina Fotteler, et al.
Frontiers in Oncology|May 9, 2022
Glioblastoma Relapses Show Increased Markers of Vulnerability to FerroptosisHelena Kram, Georg Prokop, Bernhard Haller, et al.
Current Oncology (Toronto, Ont.)|October 22, 2021
Spinal Manifestation of Malignant Primary (PLB) and Secondary Bone Lymphoma (SLB)Melanie Barz, Kaywan Aftahy, Insa Janssen, et al.
International Journal of Cancer|July 28, 2023
Multiscale quantification of morphological heterogeneity with creation of a predictor of longer survival in glioblastomaGeorg Prokop, Benedikt Wiestler, Daniel Hieber, et al.
EJNMMI Research|August 16, 2021
Visualizing cellularity and angiogenesis in newly-diagnosed glioblastoma with diffusion and perfusion MRI and FET-PET imagingFriederike Liesche-Starnecker, Georg Prokop, Igor Yakushev, et al.
Cancers|May 11, 2024
Quantitative Assessment of Tumor Contact with Neurogenic Zones and Its Effects on Survival: Insights beyond Traditional PredictorsKirsten Jung, Johanna Kempter, Georg Prokop, et al.
Cancers|October 17, 2020
Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human GlioblastomaFriederike Liesche-Starnecker, Karoline Mayer, Florian Kofler, et al.
Pageof 1